HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hairong Liu Selected Research

Chemoradiotherapy

1/2011Erlotinib resistance is altered after gemcitabine chemotherapy for recurrent non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hairong Liu Research Topics

Disease

8Neoplasms (Cancer)
02/2024 - 11/2012
4Inflammation (Inflammations)
10/2021 - 02/2013
3Wounds and Injuries (Trauma)
12/2023 - 04/2016
3Neoplasm Metastasis (Metastasis)
07/2023 - 01/2011
2Glaucoma
02/2024 - 12/2019
2Cicatrix (Scar)
02/2024 - 12/2019
2Blister (Bulla)
02/2024 - 12/2019
2Ischemia
10/2022 - 01/2020
2Genetic Predisposition to Disease (Genetic Predisposition)
02/2013 - 04/2012
2Lung Neoplasms (Lung Cancer)
02/2013 - 04/2012
1Melanoma (Melanoma, Malignant)
02/2024
1Infections
02/2024
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2024
1COVID-19
01/2024
1Cystic Fibrosis (Mucoviscidosis)
01/2023
1Cardiotoxicity
01/2023
1Residual Neoplasm
10/2021
1Non-alcoholic Fatty Liver Disease
07/2021
1Metabolic Diseases (Metabolic Disease)
07/2021
1Obesity
07/2021
1Insulin Resistance
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Chronic Hepatitis B
08/2020
1Hepatocellular Carcinoma (Hepatoma)
08/2020
1Hypoxia (Hypoxemia)
01/2020
1Brain Edema (Cerebral Edema)
01/2020
1Cerebral Hemorrhage
01/2020
1Fibrosis (Cirrhosis)
12/2019
1Burns
04/2016
1Stomach Neoplasms (Stomach Cancer)
01/2015
1Constipation
01/2015
1Adenocarcinoma
11/2012
1Brain Neoplasms (Brain Tumor)
11/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2011

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
07/2023 - 04/2012
4CytokinesIBA
01/2023 - 02/2013
2HydrogelsIBA
02/2024 - 12/2023
2CollagenIBA
07/2023 - 12/2019
2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2023
2erucylphosphocholineIBA
10/2022 - 01/2021
2MetallothioneinIBA
01/2020 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 04/2012
2Interleukin-6 (Interleukin 6)IBA
04/2016 - 02/2013
2Cisplatin (Platino)FDA LinkGeneric
11/2012 - 01/2011
1NanogelsIBA
02/2024
1RNA (Ribonucleic Acid)IBA
02/2024
1cyclo(Arg-Pro) (CI 4)IBA
01/2024
1BerberineIBA
12/2023
1HydrogenIBA
12/2023
1GelatinIBA
07/2023
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2023
1GlucocorticoidsIBA
01/2023
1Troponin IIBA
01/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2023
1LeptinIBA
01/2023
1sulforaphaneIBA
10/2022
11-dodecylpyridoxal (PLD)IBA
10/2021
1PrebioticsIBA
07/2021
1Polysaccharides (Glycans)IBA
07/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2021
125-hydroxyprotopanaxatriolIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1entecavirFDA Link
08/2020
1Tenofovir (Viread)FDA Link
08/2020
1Phosphotransferases (Kinase)IBA
01/2020
1hesperadinIBA
01/2020
1AntioxidantsIBA
01/2020
1Streptozocin (Streptozotocin)FDA Link
01/2020
1Connective Tissue Growth FactorIBA
12/2019
1Rosiglitazone (Avandia)FDA Link
12/2019
1poly(3- hydroxybutyrate)- co- (3- hydroxyvalerate)IBA
12/2019
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2018
1InterleukinsIBA
04/2016
1SB 203580IBA
04/2016
1Messenger RNA (mRNA)IBA
04/2016
1salicylhydroxamic acid (SHAM)IBA
04/2016
1Chemotactic FactorsIBA
04/2016
1p38 Mitogen-Activated Protein KinasesIBA
04/2016
1Tumor Necrosis FactorsIBA
04/2016
1OligodeoxyribonucleotidesIBA
01/2015
1Docetaxel (Taxotere)FDA Link
01/2015
1Therapeutic UsesIBA
01/2015
1StathminIBA
01/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2013
1Pemetrexed (MTA)FDA Link
11/2012
1Tyrosine Kinase InhibitorsIBA
01/2011
1GemcitabineFDA Link
01/2011
1ErbB Receptors (EGF Receptor)IBA
01/2011
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2011

Therapy/Procedure

4Therapeutics
01/2023 - 11/2012
3Drug Therapy (Chemotherapy)
10/2021 - 01/2011
2Injections
02/2024 - 12/2023
2Immunotherapy
01/2023 - 01/2023
1Trabeculectomy (Trabeculoplasty)
02/2024
1Precision Medicine
07/2023
1Filtering Surgery
12/2019
1Electroacupuncture
01/2015
1Chemoradiotherapy
01/2011
1Radiotherapy
01/2011